Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) traded down 0.4% during trading on Wednesday . The company traded as low as €51.65 ($60.06) and last traded at €52.20 ($60.70). 169,701 shares traded hands during trading, an increase of 80% from the average session volume of 94,405 shares. The stock had previously closed at €52.40 ($60.93).
Carl Zeiss Meditec Stock Down 1.8%
The company has a market capitalization of $4.85 billion, a P/E ratio of 27.82, a PEG ratio of 2.83 and a beta of 0.98. The company has a debt-to-equity ratio of 7.41, a quick ratio of 2.47 and a current ratio of 2.13. The stock has a 50 day moving average price of €58.43 and a 200 day moving average price of €56.63.
Carl Zeiss Meditec Company Profile
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
